Vous n'êtes pas connecté
PharmaDrug (CSE: PHRX) this morning revealed the strategic plans for its Sairiyo Therapeutics subsidiary in relation to the clinical development of PD-001, its patented formulation for an enteric-coated version of cepharanthine. The post PharmaDrug Subsidiary To Focus Development Of PD-001 On Viral Infectious Diseases appeared first on the deep dive.
Alterity Therapeutics has its roots in developing drugs for neurodegeneration with its latest focus on Parkinson’s disease and related disorders,...
The National Institutes of Health (NIH) has established a pandemic preparedness research network to conduct research on high-priority pathogens most...
The National Institutes of Health (NIH) has established a pandemic preparedness research network to conduct research on high-priority pathogens most...
TRIB announces updates on its European patented process. The company aims to use this process to improve the functionality of its glucose biosensor in...
TRIB announces updates on its European patented process. The company aims to use this process to improve the functionality of its glucose biosensor in...
Canada Nickel Company (TSXV: CNC) is one step closer to securing debt financing for the development of its flagship Crawford The post Canada Nickel...
Canada Nickel Company (TSXV: CNC) is one step closer to securing debt financing for the development of its flagship Crawford The post Canada Nickel...
An infectious diseases specialist says the spread of mpox in New Zealand can be limited - if people are vigilant and follow public health measures.
An infectious diseases specialist says the spread of mpox in New Zealand can be limited - if people are vigilant and follow public health measures.